Posterior mediastinal mass: Esophageal spindle cell tumor

F. Sharmila Banu1*, P. Rajeswari2

1Clinical Dietitian, Kauvery Hospital, Salem, Tamil Nadu

2Assistant Manager, Clinical Nutrition & Dietetics Kauvery Hospital, Salem, Tamil Nadu

*Correspondence

Introduction

A 62-year-old female admitted with the complaints of difficulty in swallowing x 7 – 8 months associated with pain. Known patient of Type 2 DM x 10 years on medication. Doctor assessed the patient and diagnosed to have carcinoma in esophagus.

Findings and Plan

Multilobulated mass in the posterior mediastinum involving oesophagus. The mass infiltrates the Inferior Vena Cava (IVC), the atrial wall, and the inferior pulmonary ligament, and it is densely adherent to the aorta. Contrast seen passing through anastomotic site.

Plan

VATS (Video-Assisted Thoracoscopic Surgery) to open mediastinal tumour excision with esophagectomy + Gastric pull up.

What is esophageal spindle cell tumor?

Esophageal spindle cell tumor is a rare and aggressive form of cancer, usually considered a variant of squamous cell carcinoma, characterized by both malignant epithelial cells and a spindle cell component. It develops in the esophagus, or food pipe.

Posterior mediastinal mass: Esophageal spindle cell tumor - figure 1

Image Source: peoplebeatingcancer, Esophageal Cancer — Need to Know, David Emerson

Signs and Symptom

  • Difficulty swallowing
  • Unexpected weight loss
  • Chronic heartburn & discomfort.

Causes and Risk factors

  • Tobacco use is the single largest risk factor for oesophageal cancer.
  • Heavy alcohol consumption acts together with tobacco use, significantly increasing the risk of cellular changes.
  • A diet low in fruits, vegetables, and essential micronutrients, such as zinc and vitamin A, may reduce the intake of protective antioxidants and other beneficial nutrients.
  • Physical or chemical damage to the esophageal lining can disrupt normal cell growth and, over time, contribute to the development of dysplasia.

Treatment/Management

  • Surgical option is Esophagectomy – removal of part or all of the esophagus is the large or malignant tumors.
  • Robotic or video-assisted thoracoscopic surgery (VATS) may be used based on tumor location and size.
  • Radiation Therapy is delivered post-surgery or used definitively if surgery is not an option.
  • Chemotherapy: Tumor-directed regimens are sometimes added, particularly if lymph nodes are involved or if the tumor has aggressive features.

Postoperative and Rehabilitation Care

  • The patient will not be allowed to eat or drink anything by mouth for the first several days to allow the new esophageal connection to heal.
  • While the esophagus heals, all nutrition, hydration, and medications will be administered through a temporary feeding tube, usually a J-tube placed in the abdomen.
  • The diet advances very slowly: clear liquids → full liquids → pureed foods → soft foods → regular solids.
  • The patient must eat 6-8 small meals a day instead of three large meals because the new stomach conduit cannot hold large amounts of food at once.
  • Small tumors often require minimal reconstruction, allowing for better preservation of function.
  • Patients typically need chest drains, intravenous lines, and sometimes an epidural or pain control pump in the intensive care unit.

Patient Details

Name Mrs.X
Age 62 years
Gender Female
Date of Admission 03.06.2026
Date of Discharge 13.06.2026

Anthropometric Data

Height 158cm
Weight 65 kg
BMI 26 kg/m2
IBW [Height(m2) X 24] to [Height(m2) X 27: 59kg to 67kg

Clinical Data & Diet History

Complaint Difficulty in swallowing
Diagnosis Posterior mediastinal mass: Esophageal spindle cell tumour
Past History Diabetes, Loss of appetite & weight loss (6kg in 2 month)
Personal history Nil
Diet Habit/Allergic Non vegetarian/Nil
Subjective Global Assessment Moderately malnourished

Biochemical Data

Date 03.06.26 05.06.26 06.06.26 07.06.26 08.06.26 09.06.26
Hb 12.5 14.8 11.9 11.3 10.7
PCV 38.5 47.1 37.7 37.3 35.2
WBC 9000 14470 8580
Platelet 4.11 2.69 2.84
CRP 147.3
Urea 15.8 23 25
Creatinine 0.7 0.64 0.48
Sodium 139 143 141
Potassium 3.8 4.0 4.1 3.5
Total Bilirubin 0.7
Direct 0.5
Indirect 0.2
SGOT 27
SGPT 18
GGTP 23
Total protein 7.4
Albumin 4.1 2.3
Globulin 3.4

Medical Nutritional therapy

  • Energy: To provide Adequate calories
  • Carbohydrates: To provide moderate carbohydrates to prevent protein catabolism
  • Protein: Provide for high protein for tissue repair and growth
  • Fat: To provide moderate fat
  • Fibre: Limit intake of fibre.
  • Fluids: To provide adequate fluid to maintain the hydration.
  • Micronutrient as per WHO

Post operative nutrition target

  • Energy: 2275Kcal
  • Protein: 1.5 gm/Kg of IBW (100gm)
  • CHO: 55% of total Calories
  • Protein:25% of total Calories, Fat: 20% of total calories

Diet Follow-up

Day Date Type of Diet Energy Protein Remarks
Day 1 4.06.2026 NPO
Day 2 5.06.2026 NPO
Day 3 6.06.2026 NPO(DNS-500ml/Day)
Day 4 7.06.2026 TPN – 60ml / hr
Day 5 8.06.2026 TPN – 60ml/hr + FJ feed (clear liquid-30ml/hr) 1300Kcal 50gm FJ Feed starts at 6.00am
Day 6 9.06.2026 FJ feed 1500ml/Day(50ml/hr) +Oral plain water 841Kcal 35gm No complaint
Day 7 10.06.2026 FJ feed 2500ml/Day(100ml/hr) +Oral clear liquid 30ml/hr 1982Kcal 70gm No complaint
Day 8 11.06.2026 FJ feed 3000ml/Day(125ml/hr) +Oral liquid 50ml/hr 2400Kcal 97gm Oral liquid starts at 6am.Complaint of abdomen pain at 8am.
Day 9 12.06.2026 FJ feed 3000ml/Day(125ml/hr) + Semisolid diet 2100Kcal+300(2400) 80gm+18gm Oral semisolid diet starts at 8.00am. Complaint of Gastritis at 12.30pm.
Day 10 13.06.2026 FJ feed 3000ml/Day(125ml/hr)+ soft solid diet 2100Kcal+280(2380) 80gm+15gm Soft solid diet starts at 9.00am.

Discharge Advice and Conclusion

  • Target Nutrition achieved.
  • FJ feed continues with oral high protein soft-solid diet.
  • Regular follow-up with OP
Kauvery Hospital